Menu

Vaccinex, Inc. VCNX

Full chart Compare
Set alert

Price alert · VCNX

All alert types
1.00 USD +0.30 (+42.84%)

Nov 6, 2026, 3:05 PM EST

0.752 Day range 1.00
0.38 52-week range 1.49
YTD
-7.41%
1 year
+122.22%

Revenue & Expenses

Other Income → Expenses: $2.63MExpenses → Selling, General & Admin: $6.88MExpenses → Research & Development: $16.57MExpenses → Interest Expense: $1.00KGross Profit → Expenses: $570.00KRevenue → Gross Profit: $570.00KNet Loss → Expenses: $20.25MOther Income$2.63MGross Profit$570.00KNet Loss$20.25MExpenses$23.46MSelling, General & Admin$6.88MResearch & Development$16.57MInterest Expense$1.00KRevenue$570.00K

Latest period ending Dec 31, 2023 · select a line to chart its full history

VCNX annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
570.00K275.00K900.00K625.00K523.00K
570.00K275.00K900.00K623.00K324.00K
-22.89M-19.91M-22.49M-28.33M-32.02M
-20.25M-19.82M-22.38M-28.85M-31.86M
-43.68-98.05-163.80-323.40-518.70
VCNX annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
1.53M6.39M8.59M10.60M2.78M
3.63M7.98M9.84M11.70M4.60M
5.94M2.78M2.43M14.31M6.88M
247.00K485.00K390.00K9.21M0
-2.31M5.19M7.41M-26.57M-26.24M
VCNX annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-17.23M-19.07M-25.30M-28.65M-30.71M
-67.00K-99.00K-32.00K-290.00K14.07M
12.45M16.98M23.32M36.76M13.80M
-67.00K-99.00K-32.00K-290.00K-78.00K
-4.86M-2.20M-2.01M7.82M-2.84M